POST Online Media Lite Edition


RxGenomix appoints Blake Keller as chief operating officer

Staff Writer |
Franklin, Tenn., USA - Blake Keller has joined RxGenomix, a biotechnology company, as chief operating officer.

Article continues below

Mr. Keller has served in various clinical, operational, and business development capacities over his professional career.

Mr. Keller most recently served as President, North America of Fagron, a leading pharmaceutical compounding company active in 35 countries worldwide.

Previously, he served as Vice President of Premise Health, the largest direct onsite and near-site comprehensive healthcare provider, serving hundreds of Fortune 1000 firms.

For many years, Mr. Keller has taught Doctor of Pharmacy students in advanced practice settings, developing future clinical leaders.